Roze Isono-Taniguchi
Papers
1
Total Citations
4
H-Index
1
About
Dr. Roze Isono-Taniguchi is a leading researcher in gynecologic oncology, with a particular focus on the intersection of obesity and endometrial cancer management. Her work addresses critical challenges in treating early-stage endometrial cancer (EC) and atypical endometrial hyperplasia (AEH) in severely obese patients, a population at heightened risk for perioperative complications. Her most cited study, published in 2023, investigates the use of weight-loss interventions (WLIs) combined with levonorgestrel intrauterine system implantation as a strategy to reduce surgical risks and improve outcomes. This work highlights the delicate balance between delaying surgery for weight reduction and the potential for disease progression, offering evidence-based guidance for clinical decision-making. With 4 citations to date, this paper has already garnered attention for its practical implications in managing high-risk patients. Dr. Isono-Taniguchi’s contributions are particularly valuable in advancing personalized, risk-reducing approaches in gynecologic oncology, making her a key voice in the ongoing effort to improve surgical safety and long-term outcomes for obese patients with endometrial pathologies.
Research Focus
Key Achievements
Top Papers
- 1